Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression.
Gruber
S A
SA
Department of Surgery, University of Minnesota, Minneapolis.
Skjei
K L
KL
Sothern
R B
RB
Robison
L
L
Tzardis
P
P
Moss
A
A
Gillingham
K
K
Canafax
D M
DM
Matas
A J
AJ
Dunn
D L
DL
D000367:Age Factors; D003524:Cyclosporins / Q000009:adverse effects*; D048909:Diabetes Complications; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects* / Q000379:methods; D016030:Kidney Transplantation / Q000009:adverse effects*; D008223:Lymphoma / Q000453:epidemiology / Q000209:etiology; D008297:Male; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology*; D012737:Sex Factors; D012878:Skin Neoplasms / Q000453:epidemiology / Q000209:etiology
D003524:Cyclosporins